tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
VRTX
Vertex Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRTX full AI Analyst Report?

Vertex Pharmaceuticals (VRTX) Income Statement

6,684 Followers

Vertex Pharmaceuticals Income Statement

Last quarter (Q4 2025), Vertex Pharmaceuticals's total revenue was $3.23B, an increase of 10.82% from the same quarter last year. In Q4, Vertex Pharmaceuticals's net income was $1.19B. See Vertex Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 12.07B$ 11.02B$ 9.87B$ 8.93B$ 7.57B
Gross Profit
$ 10.27B$ 9.49B$ 8.61B$ 7.85B$ 6.67B
Operating Expenses
$ 5.51B$ 9.72B$ 4.78B$ 3.54B$ 3.89B
Depreciation and Amortization
$ 207.20M$ 205.80M$ 181.30M$ 148.30M$ 125.60M
EBITDA
$ 4.97B$ 486.30M$ 4.61B$ 4.44B$ 2.92B
Operating Income
$ 4.76B$ -232.90M$ 3.83B$ 4.31B$ 2.78B
Other Income/Expenses
$ -117.50M$ 481.40M$ 547.80M$ -75.00M$ -51.70M
Pretax Income
$ 4.64B$ 248.50M$ 4.38B$ 4.23B$ 2.73B
Net Income
$ 3.95B$ -535.60M$ 3.62B$ 3.32B$ 2.34B
Per Share Metrics
Basic EPS
$ 15.46$ -2.08$ 14.05$ 12.97$ 9.09
Diluted EPS
$ 15.32$ -2.08$ 13.89$ 12.82$ 9.01
Weighted Average Shares Outstanding
 255.70M 257.50M 257.70M 256.10M 257.70M
Weighted Average Shares Outstanding (Diluted)
 258.00M 257.90M 260.50M 259.10M 259.90M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History